Drug class in one race
IL-23 receptor drugs for Psoriasis
3 tracked IL-23 receptor drugs in the Psoriasis race. The class explanation lives on the IL-23 receptor page; the full indication pipeline across every mechanism is on the Psoriasis page.
1 approved / phase 42 Phase 2
Head-to-head evidence: HS-20118 vs icotrokinra · HSK47388 vs icotrokinra